Key result
Digital health technologies show potential to improve hypertension detection and management but require further validation.
Why the study?
Hypertension remains underdiagnosed and undertreated globally, and new digital technologies for self-monitoring blood pressure require proper clinical validation before widespread use.
Answers are grounded in this paper and cite their sources.
Digital health technologies such as smartphone apps and telemonitoring show potential to improve hypertension detection and management, but require rigorous clinical validation.
Hypertension is a key risk factor for cardiovascular disease.Globally, approximately a third of people with hypertension remain undiagnosed, and of those diagnosed, about half are not taking antihypertensive medication.The World Health Organization has estimated that globally hypertension directly or indirectly causes the deaths of at least nine million people every year.There is a trend towards self-monitoring of blood pressure (BP), where patients are empowered to be involved in hypertension screening and diagnosis.Novel technology, including smartphones and Blue-tooth® enabled telemonitoring, are new tools that are likely to be increasingly important in hypertension management.Several studies have shown the benefit of selfmonitoring of BP coupled with co-interventions (such as telemonitoring) in improving BP management.However, these new technologies must be properly assessed and clinically validated prior to widespread implementation in the general population, or within special groups.In this mini-review, we examine how technology might improve the detection and management of hypertension.
No takes yet. Share an insight, caveat, or question.
Kitt et al. (2020) conducted a review in Hypertension. Digital health technologies (self-monitoring, telemonitoring, and smartphone apps) vs. Standard care was evaluated. Digital health technologies, including self-monitoring and telemonitoring, show potential to improve the detection and management of hypertension, but require further clinical validation prior to widespread implementation.
Synapse has enriched 10 related papers. Consider them for comparative context: